Simplify Health Care ETF (PINK) Fund Overview
Educational signal · not a buy or sell recommendation · How to read this
Beta 0.87: the stock has moved about 13% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerSimplify Health Care ETF (PINK) trades at $38.13. Simplify Health Care ETF (PINK) aims for long-term capital appreciation through investments in innovative healthcare companies. Sector: Financials.
Price as of · Last analyzed: Mar 16, 2026Analyst Coverage for PINK: PINK does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
Simplify Health Care ETF (PINK) Financial Services Profile
Simplify Health Care ETF (PINK) offers multi-cap exposure to pioneering biotech, medtech, and gene therapy firms. Managed by Michael Taylor, PINK distinguishes itself as a 100% pro bono ETF, allocating net profits to the Susan G. Komen foundation, thereby combining investment in healthcare innovation with charitable giving.
What Is the Investment Thesis for PINK?
Simplify Health Care ETF (PINK) presents a notable research candidate due to its focus on high-growth areas within the healthcare sector, combined with its unique pro bono structure. The ETF's multi-cap exposure allows it to capture growth across various stages of company development, from emerging biotech firms to established pharmaceutical companies. The healthcare sector is expected to continue its expansion, driven by factors such as an aging population, technological advancements, and increased healthcare spending. PINK's commitment to donating net profits to the Susan G. Komen foundation enhances its appeal to socially conscious investors. The ETF's expense ratio and tracking error relative to its benchmark will be critical factors in determining its long-term performance. The ETF's beta of 0.87 suggests lower volatility compared to the broader market, potentially making it a noteworthy option for risk-averse investors. However, the absence of a dividend yield may deter income-seeking investors.
Based on FMP financials and quantitative analysis
PINK Key Highlights
PINK provides multi-cap exposure to innovative healthcare companies, including biotech, medtech, and gene therapy firms.
- The ETF is managed by Michael Taylor, who brings over two decades of experience managing healthcare equity portfolios.
- PINK is the first 100% pro bono ETF focused on the healthcare sector, donating net profits to the Susan G. Komen foundation.
- As of 09/01/25, PINK has donated $350,000 to the Susan G. Komen foundation.
- PINK has a beta of 0.87, indicating lower volatility compared to the broader market.
Who Are PINK's Competitors?
PINK is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| CLSM ETC Cabana Target Leading Sector Moderate ETF | $28.16 | +0.57% | $100M | — |
| ESG FlexShares STOXX US ESG Select Index Fund | $181.10 | +0.44% | $136M | — |
| HIDV Alliance Bernstein - AB US High Dividend ETF | $89.66 | +0.23% | $205M | — |
| IZRL ARK Israel Innovative Technology ETF | $28.70 | -0.36% | $138M | — |
| MARM FT Vest U.S. Equity Max Buffer ETF - March | $34.61 | -0.03% | $109M | — |
| BLK BlackRock, Inc. | $1066.45 | +0.64% | $165B | 51 5-pillar |
| BX Blackstone Inc. | $111.64 | -0.09% | $136B | 68 5-pillar |
| APOS Apollo Global Management, Inc. | $25.59 | 0.00% | $74.8B | 56 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are PINK's Key Strengths?
Unique pro bono structure with donations to the Susan G. Komen foundation.
- Experienced portfolio manager with expertise in healthcare equities.
- Focus on high-growth areas within the healthcare sector.
- Multi-cap exposure provides diversification.
What Are PINK's Weaknesses?
Relatively small market capitalization of $0.13B.
- No dividend yield may deter income-seeking investors.
- Dependence on the performance of the healthcare sector.
- Potential for higher expense ratios compared to larger ETFs.
What Are the Key Risks for PINK?
Regulatory changes impacting the healthcare industry affecting the profitability of companies within the ETF's portfolio.
- Economic downturn leading to reduced healthcare spending and lower investment returns.
- Unforeseen events such as product recalls or clinical trial failures impacting the performance of individual companies within the ETF.
- Competition from other healthcare ETFs and investment funds.
- Market volatility affecting the value of healthcare stocks.
What Are PINK's Competitive Advantages?
- First 100% pro bono ETF focused on the healthcare sector.
- Donation of net profits to the Susan G. Komen foundation.
- Experienced portfolio manager with a strong track record.
- Focus on innovative and high-growth areas within healthcare.
What Does PINK Do?
The Simplify Health Care ETF (PINK) was created to provide investors with a unique opportunity to invest in the rapidly evolving healthcare sector while simultaneously contributing to a charitable cause. The ETF focuses on long-term capital appreciation by investing in a diverse range of companies, from established pharmaceutical giants to emerging biotech startups, medtech innovators, and gene therapy pioneers. PINK's investment strategy targets multi-cap exposure, ensuring a balanced portfolio that captures growth opportunities across different market capitalizations within the healthcare industry. The ETF is managed by Michael Taylor, a seasoned portfolio manager with over two decades of experience in managing long/short healthcare equity portfolios at leading hedge funds. Taylor's expertise guides the ETF's investment decisions, leveraging his deep understanding of the healthcare landscape to identify promising investment opportunities. A key differentiator of PINK is its commitment to philanthropy. As the first 100% pro bono ETF focused on the healthcare sector, PINK donates its net profits annually to the Susan G. Komen foundation, supporting breast cancer research and awareness initiatives. As of September 1, 2025, PINK has donated $350,000. PINK operates under the ticker symbol PINK and is promoted under the tagline 'Shares for the Cure,' reflecting its dual mission of investment and charitable giving. The ETF's structure allows investors to participate in the growth of the healthcare sector while making a tangible contribution to a worthy cause. Simplify Health Care ETF presents a compelling option for investors seeking both financial returns and social impact.
What Products and Services Does PINK Offer?
- Invests in multi-cap healthcare companies.
- Focuses on biotech, medtech, and gene therapy sectors.
- Seeks long-term capital appreciation.
- Donates net profits to the Susan G. Komen foundation.
- Provides exposure to innovative healthcare companies.
- Managed by experienced portfolio manager Michael Taylor.
How Does PINK Make Money?
- Generates revenue through investment gains in healthcare companies.
- Operates as an Exchange Traded Fund (ETF).
- Attracts investors seeking exposure to the healthcare sector.
- Donates net profits to charity.
What Industry Does PINK Operate In?
The asset management industry is characterized by intense competition, with numerous ETFs and mutual funds vying for investor capital. The healthcare sector, in particular, has attracted significant investment due to its growth potential and defensive characteristics. Simplify Health Care ETF (PINK) differentiates itself through its pro bono structure and focus on innovative healthcare companies. The ETF operates in a market driven by trends such as technological advancements in medicine, increasing healthcare spending, and an aging global population. Competitors like CLSM, ESG, HIDV, IZRL, and MARM offer alternative investment options within the healthcare and ESG sectors, requiring PINK to demonstrate superior performance and social impact to attract and retain investors.
Who Are PINK's Key Customers?
- Retail investors interested in healthcare.
- Institutional investors seeking socially responsible investments.
- Investors looking for long-term capital appreciation.
- Individuals and organizations supporting breast cancer research.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
- ● This is an etf, not an operating company
MoonshotScore History
Recorded daily since 2026-08-23 · 41 snapshots
| 2026-08-23 | 46 |
| 2026-08-31 | 46 |
| 2026-09-08 | 46 |
| 2026-09-16 | 46 |
| 2026-09-24 | 46 |
| 2026-10-04 | 46 |
What changed?
The score has stayed at 46.
Over the same 30 days the stock moved -3.9%.
PINK Financials
Bull Case vs Bear Case
Bull Case
- Unique pro bono structure with donations to the Susan G. Komen foundation.
- Experienced portfolio manager with expertise in healthcare equities.
- Focus on high-growth areas within the healthcare sector.
- Multi-cap exposure provides diversification.
Bear Case
- Relatively small market capitalization of $0.13B.
- No dividend yield may deter income-seeking investors.
- Dependence on the performance of the healthcare sector.
- Potential for higher expense ratios compared to larger ETFs.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
PINK Latest News
-
Why Is Eli Lilly Stock Falling Tuesday?
benzinga · Sep 8, 2026
-
Can Victoria's Secret Keep PINK Growing After Five Strong Quarters?
zacks.com · Sep 7, 2026
-
Vanguard Health Care ETF vs Simplify Health Care ETF
fool.com · Sep 1, 2026
-
Medical Care Technologies (OTC PINK:MDCE) Advances AI Longitudinal Body-Map Monitoring Capabilities Within its Melanoma Scan Beta App
accessnewswire.com · Aug 26, 2026
PINK Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for PINK.
Price Targets
Wall Street price target analysis for PINK.
PINK MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for PINK; grades run from A+ (80-100) to F (below 30).
Latest News
Why Is Eli Lilly Stock Falling Tuesday?
Can Victoria's Secret Keep PINK Growing After Five Strong Quarters?
Vanguard Health Care ETF vs Simplify Health Care ETF
Medical Care Technologies (OTC PINK:MDCE) Advances AI Longitudinal Body-Map Monitoring Capabilities Within its Melanoma Scan Beta App
PINK Financials Stock FAQ
How does PINK's pro bono structure impact its financial performance?
PINK's pro bono structure, where net profits are donated to the Susan G. Komen foundation, does not directly impact the ETF's investment strategy or expense ratio.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Further analysis is required to determine the ETF's long-term performance and risk profile.
- The information provided is based on available data and should not be considered investment advice.